Huang and colleagues also demonstrated that treatment with IFN-γ has a synergistic effect when combined with the conventional oxaliplatin treatment in eliminating both CSCs and differentiated CRC cells (87). The gene discussed is IFNG; the disease is colorectal carcinoma.